Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute leukemia

A Ganser1, D Hoelzer

  • 1Department of Internal Medicine III, Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany.

Current Opinion in Hematology
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Recent advancements enhance acute leukemia molecular understanding and minimal residual disease detection. Key findings link multidrug resistance gene expression to treatment response and identify bone marrow transplantation as superior for high-risk leukemia patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

Bone marrow transplantation·2023
Same author

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Scientific reports·2023
Same author

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020
Same author

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.

Bone marrow transplantation·2019
Same author

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019
Same author

Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation-are we aware of this side effect?

Annals of hematology·2018
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Significant progress in understanding molecular changes in acute leukemia.
  • Improved detection of minimal residual disease using molecular probes.

Purpose of the Study:

  • To review recent advancements in acute leukemia molecular understanding and treatment.
  • To highlight correlations between molecular markers and treatment outcomes.

Main Methods:

  • Review of recent studies on molecular alterations in acute leukemia.
  • Analysis of correlations between gene expression (mdr-1, bcl-2) and surface antigens (CD34, CD7).
  • Evaluation of hematopoietic growth factors and bone marrow transplantation efficacy.

Main Results:

Related Experiment Videos

  • Multidrug resistance gene expression correlates with chemotherapy response and specific surface antigens.
  • All-trans retinoic acid combined with chemotherapy is standard for acute promyelocytic leukemia.
  • Allogeneic bone marrow transplantation shows superiority in high-risk acute leukemia, including Philadelphia chromosome-positive acute lymphoblastic leukemia.

Conclusions:

  • Molecular insights are improving acute leukemia diagnosis and treatment strategies.
  • Bone marrow transplantation is a critical option for specific high-risk leukemia patient groups.
  • Ongoing research continues to define the roles of various therapies and molecular markers.